Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

BMS Drug Approved for CHB

October 18, 2010 8:00 am | News | Comments

Bristol-Myers Squibb Company announced that the FDA has approved the supplemental New Drug Application of BARACLUDE for the treatment of chronic hepatitis B in adult patients with decompensated liver disease.


Botox Given Go-Ahead to Treat Migraines

October 18, 2010 7:56 am | News | Comments

Federal health officials approved the wrinkle-smoothing injection Botox for migraine headaches, giving drugmaker Allergan clearance to begin marketing its drug to patients with a serious history of the condition.


J & J Ordered to Pay Louisiana Over Quarter Billion

October 18, 2010 7:54 am | News | Comments

A Louisiana jury says health products maker Johnson & Johnson owes the state nearly $258 million for misleading doctors about the possible side effects of one of its anti-psychotic medications.


Humorous PSAs Target Malaria

October 18, 2010 7:51 am | by John Carucci | News | Comments

A new public service announcement irreverently suggests one way to solve the malaria problem in Africa: Recruit a cadre of sexy mosquitoes called La Femme Mosquita to seduce and kill their disease-carrying counterparts.


Controlled-Rate Freezer

October 15, 2010 8:44 am | Product Releases | Comments

The Bio-Cool from SP Scientific is the only controlled rate freezer that does not require expendable liquid nitrogen and the associated pumping, re-filling, and storage challenges posed by a cryogenic liquid.



October 15, 2010 8:39 am | Product Releases | Comments

JM Science’s AQUACOUNTER Coulometric Karl Fischer Titrator (AQ-300) has state-of-the-art performance features like a fritless cell option and it offers fast and accurate results.


Fate And BD Collaborate on Stem Cells

October 15, 2010 8:21 am | News | Comments

Fate Therapeutics, Inc. has forged a collaboration and license agreement with BD through its BD Biosciences segment, for the joint development and worldwide commercialization of induced pluripotent stem cell tools and technologies for drug discovery and development.


Biofocus Expands Work With Chiesi

October 15, 2010 8:17 am | News | Comments

BioFocus, a leading provider of integrated gene-to-clinical candidate drug discovery services, announced that it has expanded a collaboration with Chiesi Farmaceutici, a privately held Italian pharmaceutical company.


New Delivery Mechanism for MS Drug

October 15, 2010 8:06 am | News | Comments

Merck KGaA announced the upcoming introduction of the new device RebiDose, the Rebif single use pre-filled pen, for the self-administration of Rebif (interferon beta-1a), a disease-modifying drug used to treat relapsing forms of multiple sclerosis.


Study Uncovers a New Gene for Memory

October 15, 2010 7:56 am | News | Comments

Researchers have identified a new gene that is required for memory formation in Drosophila, the common fruit fly. The gene may have similar functions in humans, shedding light on neurological disorders such as Alzheimer’s disease.


Rewiring a Damaged Brain

October 15, 2010 7:50 am | News | Comments

Researchers are developing microelectronic circuitry to guide the growth of axons in a brain damaged by an exploding bomb, car crash, or stroke. The goal is to rewire the brain connectivity and bypass the region damaged by trauma.


Inflammation Causes Some Postsurgical Neuropathies

October 15, 2010 7:48 am | News | Comments

A new study has found that nerve inflammation may cause the pain, numbness, and weakness following surgical procedures. Known as postsurgical neuropathy, it has typically been attributed to compression or stretching of nerves during surgery.


Study Identifies Genetic Risk Factor for ALS

October 15, 2010 7:44 am | News | Comments

A study led by researchers from the University of Pennsylvania has identified a new genetic risk factor for amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease.


Warning Letters Sent to Eight Companies

October 15, 2010 7:32 am | by Matthew Perrone | News | Comments

The Food and Drug Administration warned eight companies to stop marketing miracle cures that claim to treat everything from autism to Parkinson's disease by flushing toxic metals from the body.


Leishmanisis Outbreak Effects Thousands

October 15, 2010 7:30 am | by Robert Kennedy | News | Comments

An outbreak of a tropical disease caused by sand fly bites that leaves disfiguring skin sores has hit Afghanistan, with tens of thousands of people infected, health officials said.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.